Related Experiment Video
Updated: Feb 25, 2026

05:41
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
Published on: April 6, 2022
3.5K
A pilot study demonstrating the altered gut microbiota functionality in stable adults with Cystic Fibrosis
F Fouhy1, N J Ronan2,3, O O'Sullivan1,4
1Teagasc Food Research Centre, Moorepark, Fermoy, Co. Cork, Ireland.
Scientific Reports
|July 29, 2017
Summary
Cystic Fibrosis (CF) alters gut microbiota functionality, impacting lipid and xenobiotic metabolism. This study found significant differences in adult CF patients compared to controls, highlighting the need for further research.
Area of Science:
- Microbiology
- Gastroenterology
- Metabolomics
Background:
- Cystic Fibrosis (CF) and its treatments significantly alter gut microbiota composition.
- The functional consequences of these microbiota alterations in CF patients remain largely uncharacterized.
Purpose of the Study:
- To investigate measurable changes in gut microbiota functionality in adult CF patients compared to healthy controls.
- To establish a proof-of-principle for functional analysis of the CF gut microbiome.
Main Methods:
- Faecal samples were collected from six adult CF patients and six non-CF controls.
- Shotgun metagenomic sequencing was performed on extracted DNA.
- Metabolomic analysis utilized gas chromatography-mass spectrometry on faecal water.
Main Results:
- Gut microbiota composition differed significantly, with increased Firmicutes and decreased Bacteroidetes in CF patients.
- Altered functionality was observed, including higher pathway abundances in lipid and xenobiotic metabolism in CF patients.
- Significant differences in fecal metabolites were detected between CF patients and controls.
Conclusions:
- Measurable changes in gut microbiota functionality are evident in adult CF patients.
- These findings support the need for larger studies to further explore gut microbiome function in Cystic Fibrosis.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
944
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
944
Cystic Fibrosis: Management
580
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
580
Anatomy of the Intestines
88.5K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
88.5K

